EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Advanced Bioresin Formulation for 3D-Printed Bone Scaffolds: PCLDMA and p-PLA Integration

Deniz Sakarya iD, Tolga Zorlu iD, Sevil Yücel, Yesim Muge Sahin iD, Ali Can Özarslan iD

Polymers · 16.02.2024 · 16 (4) · 534

DOI: 10.3390/polym16040534 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Polymers, online erschienen am 16.02.2024. Verfasst von Deniz Sakarya und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Nanotechnology and Biotechnology, İstanbul University-Cerrahpaşa, Istanbul 34500, Turkey. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In bone tissue engineering, scaffold attributes such as pore dimensions and mechanical strength are crucial. This study synthesized polycaprolactone dimethacrylate (PCLDMA) from polycaprolactone (PCL), incorporating epichlorohydrin (Epi-PCL) and methacryloyl chloride (Meth-Cl). PCLDMA was blended with polylactic acid (p-PLA) to 3D-print bone scaffolds using stereolithography (SLA). Analytical techniques included nuclear magnetic resonance (NMR), Fourier-transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM), and compression testing. Degradation kinetics and cell viability were investigated using human osteoblast (HOB) cells. Findings revealed PCLDMA/p-PLA composite scaffold superiority over the original polymers. Notably, PCLDMA-60 (60% PCLDMA, 40% p-PLA) displayed optimal properties. Compressive strength varied from 0.019 to 16.185 MPa, porosity from 2% to 50%, and degradation rates from 0% to 0.4% over three days. Cell viability assays affirmed biocompatibility across various PCLDMA ratios. In conclusion, PCLDMA/p-PLA composite scaffolds, particularly PCLDMA-60, show great potential in bone tissue engineering.

Schlagwörter

Stichwörter der Autor:innen

bone regenerationbone tissue scaffoldcomposite materialspolycaprolactone dimethacrylate (PCLDMA)polylactic acid (PLA)

Autor:innen und Institutionen

  • Institute of Nanotechnology and Biotechnology, İstanbul University-Cerrahpaşa, Istanbul 34500, Turkey.
  • Faculty of Chemistry-Metallurgy, Bioengineering Department, Yildiz Technical University, Istanbul 34210, Turkey.
  • Faculty of Chemistry, Institute of Functional Materials and Catalysis, University of Vienna, 1090 Vienna, Austria.
  • Polymer Technologies and Composite Application and Research Center (ArelPOTKAM), Istanbul Arel University, Buyukcekmece, Istanbul 34537, Turkey.

ORCID-Profile: Deniz Sakarya, Tolga Zorlu, Yesim Muge Sahin, Ali Can Özarslan

Zitieren

APA

Sakarya, D., Zorlu, T., Yücel, S., Sahin, Y. M., & Özarslan, A. C. (2024). Advanced Bioresin Formulation for 3D-Printed Bone Scaffolds: PCLDMA and p-PLA Integration. Polymers, 16(4), 534. https://doi.org/10.3390/polym16040534

Vancouver

Sakarya D, Zorlu T, Yücel S, Sahin YM, Özarslan AC. Advanced Bioresin Formulation for 3D-Printed Bone Scaffolds: PCLDMA and p-PLA Integration. Polymers. 2024;16(4):534. doi:10.3390/polym16040534

BibTeX
@article{Sakarya2024,
  author = {Sakarya, Deniz and Zorlu, Tolga and Yücel, Sevil and Sahin, Yesim Muge and Özarslan, Ali Can},
  title = {Advanced Bioresin Formulation for 3D-Printed Bone Scaffolds: PCLDMA and p-PLA Integration},
  journal = {Polymers},
  year = {2024},
  volume = {16},
  number = {4},
  pages = {534},
  doi = {10.3390/polym16040534}
}
Kostenlos starten →